BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, Erfan Rasouli S, Hamedifar H, Sabzevari A, Chavoshzadeh Z, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review. Pediatr Allergy Immunol 2021. [PMID: 33963613 DOI: 10.1111/pai.13535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lambert MP. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS). Expert Rev Clin Immunol 2021;17:1163-73. [PMID: 34503378 DOI: 10.1080/1744666X.2021.1978842] [Reference Citation Analysis]
2 Wang C, Walter JE. Autoantibodies in immunodeficiency syndromes: The Janus faces of immune dysregulation. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100948] [Reference Citation Analysis]
3 Szczawińska-Popłonyk A, Grześk E, Schwartzmann E, Materna-Kiryluk A, Małdyk J. Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge. Front Pediatr 2021;9:798959. [PMID: 35036396 DOI: 10.3389/fped.2021.798959] [Reference Citation Analysis]
4 Consonni F, Gambineri E, Favre C. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies. Ann Hematol. [DOI: 10.1007/s00277-022-04761-7] [Reference Citation Analysis]
5 Magerus A, Bercher-Brayer C, Rieux-Laucat F. The genetic landscape of the FAS pathway deficiencies. Biomed J 2021:S2319-4170(21)00071-8. [PMID: 34171534 DOI: 10.1016/j.bj.2021.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]